These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 21211484)
1. Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study. Leendertse AJ; Van Den Bemt PM; Poolman JB; Stoker LJ; Egberts AC; Postma MJ Value Health; 2011 Jan; 14(1):34-40. PubMed ID: 21211484 [TBL] [Abstract][Full Text] [Related]
2. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study. Kunac DL; Kennedy J; Austin N; Reith D Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935 [TBL] [Abstract][Full Text] [Related]
3. Practical approach to determining costs and frequency of adverse drug events in a health care network. Senst BL; Achusim LE; Genest RP; Cosentino LA; Ford CC; Little JA; Raybon SJ; Bates DW Am J Health Syst Pharm; 2001 Jun; 58(12):1126-32. PubMed ID: 11449856 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for hospital admissions associated with adverse drug events. Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895 [TBL] [Abstract][Full Text] [Related]
5. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Leendertse AJ; Egberts AC; Stoker LJ; van den Bemt PM; Arch Intern Med; 2008 Sep; 168(17):1890-6. PubMed ID: 18809816 [TBL] [Abstract][Full Text] [Related]
6. Nature, occurrence and consequences of medication-related adverse events during hospitalization: a retrospective chart review in the Netherlands. Hoonhout LH; de Bruijne MC; Wagner C; Asscheman H; van der Wal G; van Tulder MW Drug Saf; 2010 Oct; 33(10):853-64. PubMed ID: 20812770 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of an electronic medication ordering system (CPOE/CDSS) in hospitalized patients. Vermeulen KM; van Doormaal JE; Zaal RJ; Mol PG; Lenderink AW; Haaijer-Ruskamp FM; Kosterink JG; van den Bemt PM Int J Med Inform; 2014 Aug; 83(8):572-80. PubMed ID: 24929633 [TBL] [Abstract][Full Text] [Related]
8. Medication errors resulting in harm: Using chargemaster data to determine association with cost of hospitalization and length of stay. McCarthy BC; Tuiskula KA; Driscoll TP; Davis AM Am J Health Syst Pharm; 2017 Dec; 74(23 Supplement 4):S102-S107. PubMed ID: 29167147 [TBL] [Abstract][Full Text] [Related]
9. Direct health care costs of hospital admissions due to adverse events in The Netherlands. Magdelijns FJ; Stassen PM; Stehouwer CD; Pijpers E Eur J Public Health; 2014 Dec; 24(6):1028-33. PubMed ID: 24699427 [TBL] [Abstract][Full Text] [Related]
10. Adverse drug events resulting in admission to the intensive care unit in oncology patients: Incidence, characteristics and associated cost. Nazer LH; Eljaber R; Rimawi D; Hawari FI J Oncol Pharm Pract; 2013 Dec; 19(4):298-304. PubMed ID: 23223402 [TBL] [Abstract][Full Text] [Related]
11. Incidence of adverse drug events in an academic hospital: a prospective cohort study. Aljadhey H; Mahmoud MA; Mayet A; Alshaikh M; Ahmed Y; Murray MD; Bates DW Int J Qual Health Care; 2013 Dec; 25(6):648-55. PubMed ID: 24141014 [TBL] [Abstract][Full Text] [Related]
12. Effect of a ward-based pharmacy team on preventable adverse drug events in surgical patients (SUREPILL study). Surgery and Pharmacy in Liaison (SUREPILL) Study Group Br J Surg; 2015 Sep; 102(10):1204-12. PubMed ID: 26179814 [TBL] [Abstract][Full Text] [Related]
13. Adverse Drug reactions in an Ageing PopulaTion (ADAPT) study protocol: a cross-sectional and prospective cohort study of hospital admissions related to adverse drug reactions in older patients. Cahir C; Curran C; Byrne C; Walsh C; Hickey A; Williams DJ; Bennett K BMJ Open; 2017 Jun; 7(6):e017322. PubMed ID: 28600381 [TBL] [Abstract][Full Text] [Related]
14. Contribution of renal impairment to potentially preventable medication-related hospital admissions. Leendertse AJ; van Dijk EA; De Smet PA; Egberts TC; van den Bemt PM Ann Pharmacother; 2012 May; 46(5):625-33. PubMed ID: 22570433 [TBL] [Abstract][Full Text] [Related]
15. Medication safety in a psychiatric hospital. Rothschild JM; Mann K; Keohane CA; Williams DH; Foskett C; Rosen SL; Flaherty L; Chu JA; Bates DW Gen Hosp Psychiatry; 2007; 29(2):156-62. PubMed ID: 17336665 [TBL] [Abstract][Full Text] [Related]
16. Preventable medication-related events in hospitalised children in New Zealand. Kunac DL; Reith DM N Z Med J; 2008 Apr; 121(1272):17-32. PubMed ID: 18425151 [TBL] [Abstract][Full Text] [Related]
17. The medication minefield: using computerized decision support systems to reduce preventable adverse drug events and hospitalizations. Bernstein R; Kogan P; Collins A J Ambul Care Manage; 2014; 37(3):226-40. PubMed ID: 24887524 [TBL] [Abstract][Full Text] [Related]
18. The costs of adverse drug events in community hospitals. Hug BL; Keohane C; Seger DL; Yoon C; Bates DW Jt Comm J Qual Patient Saf; 2012 Mar; 38(3):120-6. PubMed ID: 22435229 [TBL] [Abstract][Full Text] [Related]
19. Adverse drug events in hospitalized children at Ethiopian University Hospital: a prospective observational study. Eshetie TC; Hailemeskel B; Mekonnen N; Paulos G; Mekonnen AB; Girma T BMC Pediatr; 2015 Jul; 15():83. PubMed ID: 26173560 [TBL] [Abstract][Full Text] [Related]